Human Phenotype
Ontology
|
Grandparent Node: Onset (HP:0003674) | Parent Node: Adult onset (HP:0003581) | ..Starting node ..Middle age onset (HP:0003596)
|
Term ID: |
3596 |
Name: |
Middle age onset |
Synonym: |
|
Definition: |
A type of adult onset with onset of symptoms at the age of 40 to 60 years. |
Comments: |
|
Reference: |
HP:0003596 |
Genes and Diseases: | | Child Nodes: | Sister Nodes: | ..Late onset (HP:0003584)
| ..Young adult onset (HP:0011462)
| Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: | HPO disease - gene - phenotype less frequent non-typical associations: | HP:0003596 | HP:0003596 | Middle age onset | 0 | AARS1 CL E G H | 16 | 20 | OMIM:613287 | Charcot-Marie-Tooth disease, axonal, type 2N | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ABCC9 CL E G H | 10060 | 60 | OMIM:614050 | Atrial fibrillation, familial, 12 | | | | 254 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ABCC9 CL E G H | 10060 | 60 | OMIM:608569 | CARDIOMYOPATHY, DILATED, 1O; CMD1O | | | | 254 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ACTC1 CL E G H | 70 | 143 | OMIM:613424 | Cardiomyopathy, dilated, 1R | | | | 208 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ACTC1 CL E G H | 70 | 143 | OMIM:612098 | Cardiomyopathy, familial hypertrophic, 11 | | | | 208 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ANXA11 CL E G H | 311 | 535 | OMIM:617839 | Amyotrophic lateral sclerosis 23 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ANXA11 CL E G H | 311 | 535 | OMIM:619733 | INCLUSION BODY MYOPATHY AND BRAIN WHITE MATTER ABNORMALITIES; IBMWMA | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | APC CL E G H | 324 | 583 | OMIM:135290 | Desmoid disease, hereditary | | | | 3179 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | APOE CL E G H | 348 | 613 | OMIM:606889 | Alzheimer disease 4 | | | | 39 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ATN1 CL E G H | 1822 | 3033 | OMIM:125370 | Dentatorubral-Pallidoluysian atrophy naito-oyanagi disease haw river syndrome ataxia, chorea, seizures, and dementia | | | | 16 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ATP2B2 CL E G H | 491 | 815 | OMIM:619804 | DEAFNESS, AUTOSOMAL DOMINANT 82; DFNA82 | | | | 5 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ATP6AP2 CL E G H | 10159 | 18305 | OMIM:300911 | Parkinsonism with spasticity, X-linked | | | | 36 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ATXN10 CL E G H | 25814 | 10549 | OMIM:603516 | Spinocerebellar ataxia 10 | | | | 9 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | BAG3 CL E G H | 9531 | 939 | OMIM:613881 | Cardiomyopathy, dilated, 1hh | | | | 204 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | BAP1 CL E G H | 8314 | 950 | OMIM:614327 | Tumor predisposition syndrome | | | | 184 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | BMPR2 CL E G H | 659 | 1078 | OMIM:178600 | Pulmonary hypertension, primary, 1 | | | | 525 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | BRCA1 CL E G H | 672 | 1100 | OMIM:604370 | Breast-Ovarian cancer, familial, susceptibility to, 1 | | | | 5769 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | BVES CL E G H | 11149 | 1152 | OMIM:616812 | Muscular dystrophy, limb-girdle, autosomal recessive 25 | | | | 2 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CADM3 CL E G H | 57863 | 17601 | OMIM:619519 | CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2FF; CMT2FF | | | | 1 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CAPN3 CL E G H | 825 | 1480 | OMIM:618129 | Muscular dystrophy, limb-girdle, autosomal dominant 4 | | | | 323 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CASK CL E G H | 8573 | 1497 | OMIM:300908 | Anemia, nonspherocytic hemolytic, due to g6pd deficiency | | | | 118 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CAV1 CL E G H | 857 | 1527 | OMIM:615343 | Pulmonary hypertension, primary, 3 | | | | 11 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CCNF CL E G H | 899 | 1591 | OMIM:619141 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5; FTDALS5 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CDH2 CL E G H | 1000 | 1759 | OMIM:618920 | ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 14; ARVD14 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CHCHD10 CL E G H | 400916 | 15559 | OMIM:615911 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 | | | | 11 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CHCHD10 CL E G H | 400916 | 15559 | OMIM:615048 | Spinal muscular atrophy, Jokela type | | | | 11 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CHMP2B CL E G H | 25978 | 24537 | OMIM:600795 | Frontotemporal dementia and/or amytrophic lateral sclerosis 7 | | | | 42 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CHRNA1 CL E G H | 1134 | 1955 | OMIM:601462 | Myasthenic syndrome, congenital, 1A, slow-channel | | | | 74 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CLCN2 CL E G H | 1181 | 2020 | OMIM:615651 | Leukoencephalopathy with ataxia | | | | 44 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CLEC3B CL E G H | 7123 | 11891 | OMIM:619977 | | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CLN6 CL E G H | 54982 | 2077 | OMIM:204300 | Ceroid lipofuscinosis, neuronal, 4A, autosomal recessive | | | | 143 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CNBP CL E G H | 7555 | 13164 | OMIM:602668 | Dystrophia myotonica 2 | | | | 1 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | COL4A1 CL E G H | 1282 | 2202 | OMIM:618564 | MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL | | | | 193 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CRYAB CL E G H | 1410 | 2389 | OMIM:615184 | Cardiomyopathy, dilated, 1ii | | | | 46 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CSF1R CL E G H | 1436 | 2433 | OMIM:221820 | Leukoencephalopathy, diffuse hereditary, with spheroids | | | | 149 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CYLD CL E G H | 1540 | 2584 | OMIM:619132 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 8; FTDALS8 | | | | 126 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | CYP7B1 CL E G H | 9420 | 2652 | OMIM:270800 | Spastic paraplegia 5A, autosomal recessive | | | | 57 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | DRD5 CL E G H | 1816 | 3026 | OMIM:606798 | Blepharospasm, benign essential, susceptibility to | . | | | 3 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | DSC2 CL E G H | 1824 | 3036 | OMIM:610476 | Arrhythmogenic right ventricular dysplasia, familial, 11 | | | | 268 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | DSG2 CL E G H | 1829 | 3049 | OMIM:610193 | Arrhythmogenic right ventricular dysplasia, familial, 10 | | | | 358 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | EIF2AK4 CL E G H | 440275 | 19687 | OMIM:234810 | PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2 | | | | 40 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ELOVL4 CL E G H | 6785 | 14415 | OMIM:133190 | Spinocerebellar ataxia 34 | | | | 62 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | EPCAM CL E G H | 4072 | 11529 | OMIM:613244 | Colorectal cancer, hereditary nonpolyposis, type 8 | | | | 170 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ERBB4 CL E G H | 2066 | 3432 | OMIM:615515 | Amyotrophic lateral sclerosis 19 | | | | 15 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | FBLN5 CL E G H | 10516 | 3602 | OMIM:608895 | Macular degeneration, age-related, 3 | | | | 63 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | FBN1 CL E G H | 2200 | 3603 | OMIM:129600 | ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1 | | | | 1361 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | FKTN CL E G H | 2218 | 3622 | OMIM:611615 | Cardiomyopathy, dilated, 1X | | | | 184 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | FLNC CL E G H | 2318 | 3756 | OMIM:617047 | Cardiomyopathy, familial hypertrophic, 26 | | | | 197 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | FTL CL E G H | 2512 | 3999 | OMIM:606159 | Neurodegeneration with brain iron accumulation 3 | | | | 33 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | G6PD CL E G H | 2539 | 4057 | OMIM:300908 | Anemia, nonspherocytic hemolytic, due to g6pd deficiency | | | | 101 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | GANAB CL E G H | 23193 | 4138 | OMIM:600666 | Polycystic kidney disease 3 | | | | 6 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | GATAD1 CL E G H | 57798 | 29941 | OMIM:614672 | Cardiomyopathy, dilated, 2B | | | | 35 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | GBE1 CL E G H | 2632 | 4180 | OMIM:263570 | Polyglucosan body neuropathy, adult form | | | | 86 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | GBF1 CL E G H | 8729 | 4181 | OMIM:606483 | Charcot-Marie-Tooth disease, dominant intermediate A | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | GJA5 CL E G H | 2702 | 4279 | OMIM:614049 | Atrial fibrillation, familial, 11 | | | | 39 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | GYG1 CL E G H | 2992 | 4699 | OMIM:616199 | Polyglucosan body myopathy 2 | | | | 18 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | H6PD CL E G H | 9563 | 4795 | OMIM:604931 | Cortisone reductase deficiency 1 | | | | 8 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | HAVCR2 CL E G H | 84868 | 18437 | OMIM:618398 | T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | HKDC1 CL E G H | 80201 | 23302 | OMIM:619614 | RETINITIS PIGMENTOSA 92; RP92 | | | | 2 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | HNRNPA1 CL E G H | 3178 | 5031 | OMIM:615424 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3 | | | | 31 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | HTRA1 CL E G H | 5654 | 9476 | OMIM:600142 | Autosomal recessive cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) | | | | 34 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | HTRA1 CL E G H | 5654 | 9476 | OMIM:616779 | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | | | | 34 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | IKZF1 CL E G H | 10320 | 13176 | OMIM:616873 | IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13 | | | | 8 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | IMPG2 CL E G H | 50939 | 18362 | OMIM:616152 | Macular dystrophy, vitelliform, 5 | | | | 120 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ITM2B CL E G H | 9445 | 6174 | OMIM:616079 | Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities | | | | 3 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | JAK2 CL E G H | 3717 | 6192 | OMIM:263300 | Polycythemia vera | | | | 57 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KCNA5 CL E G H | 3741 | 6224 | OMIM:612240 | Atrial fibrillation, familial, 7 | | | | 38 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KCNC3 CL E G H | 3748 | 6235 | OMIM:605259 | Spinocerebellar ataxia 13 | | | | 17 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KCND3 CL E G H | 3752 | 6239 | OMIM:616399 | Brugada syndrome 9 | | | | 35 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KCNE2 CL E G H | 9992 | 6242 | OMIM:611493 | ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4 | | | | 43 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KCNJ18 CL E G H | 100134444 | 39080 | OMIM:613239 | Thyrotoxic periodic paralysis, susceptibility to, 2 | | | | 10 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KCNJ2 CL E G H | 3759 | 6263 | OMIM:613980 | Atrial fibrillation, familial, 9 | | | | 193 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KCNK3 CL E G H | 3777 | 6278 | OMIM:615344 | Pulmonary hypertension, primary, 4 | | | | 7 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KCNQ1 CL E G H | 3784 | 6294 | OMIM:607554 | Atrial fibrillation, familial, 3 | | | | 730 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KIF1B CL E G H | 23095 | 16636 | OMIM:118210 | Charcot-Marie-Tooth disease, axonal, type 2A1 | | | | 202 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KIF5A CL E G H | 3798 | 6323 | OMIM:617921 | Amyotrophic lateral sclerosis, susceptibility to, 25 | | | | 93 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | KNG1 CL E G H | 3827 | 6383 | OMIM:619363 | ANGIOEDEMA, HEREDITARY, 6; HAE6 | | | | 7 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | LAMA4 CL E G H | 3910 | 6484 | OMIM:615235 | Cardiomyopathy, dilated, 1jj | | | | 279 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | LGI1 CL E G H | 9211 | 6572 | OMIM:600512 | EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1 | | | | 75 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | LITAF CL E G H | 9516 | 16841 | OMIM:601098 | Charcot-Marie-Tooth disease, demyelinating, type 1C | | | | 74 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | LMNA CL E G H | 4000 | 6636 | OMIM:115200 | Cardiomyopathy, dilated, 1A | | | | 645 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | LMX1B CL E G H | 4010 | 6654 | OMIM:256020 | NAIL-PATELLA-LIKE RENAL DISEASE | | | | 165 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | LRIF1 CL E G H | 55791 | 30299 | OMIM:619477 | FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 3, DIGENIC; FSHD3 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | LRP12 CL E G H | 29967 | 31708 | OMIM:164310 | Oculopharyngodistal myopathy 1 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MAFA CL E G H | 389692 | 23145 | OMIM:147630 | Insulinomatosis and diabetes mellitus | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MAK CL E G H | 4117 | 6816 | OMIM:614181 | Retinitis pigmentosa 62 | | | | 53 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MAP1B CL E G H | 4131 | 6836 | OMIM:619808 | DEAFNESS, AUTOSOMAL DOMINANT 83; DFNA83 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MAPT CL E G H | 4137 | 6893 | OMIM:600274 | Frontotemporal dementia | | | | 140 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MARS1 CL E G H | 4141 | 6898 | OMIM:616280 | Charcot-Marie-Tooth disease, axonal, type 2U | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MARS2 CL E G H | 92935 | 25133 | OMIM:611390 | Spastic ataxia 3, autosomal recessive | | | | 25 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MATR3 CL E G H | 9782 | 6912 | OMIM:606070 | Amyotrophic lateral sclerosis 21 | | | | 80 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MBD4 CL E G H | 8930 | 6919 | OMIM:619975 | | | | | 1 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MICAL1 CL E G H | 64780 | 20619 | OMIM:600512 | EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MLH1 CL E G H | 4292 | 7127 | OMIM:158320 | Muir-Torre syndrome | | | | 1819 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MME CL E G H | 4311 | 7154 | OMIM:617018 | SPINOCEREBELLAR ATAXIA 43; SCA43 | | | | 18 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MOCOS CL E G H | 55034 | 18234 | OMIM:603592 | Xanthinuria, type II | | | | 4 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MPZ CL E G H | 4359 | 7225 | OMIM:607736 | Charcot-Marie-Tooth disease, type 2J | | | | 134 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MSH2 CL E G H | 4436 | 7325 | OMIM:158320 | Muir-Torre syndrome | | | | 2162 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MSH3 CL E G H | 4437 | 7326 | OMIM:617100 | Familial adenomatous polyposis 4 | | | | 5 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MYH6 CL E G H | 4624 | 7576 | OMIM:613252 | Cardiomyopathy, dilated, 1ee | | | | 452 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MYORG CL E G H | 57462 | 19918 | OMIM:618317 | Basal ganglia calcification, idiopathic, 7, autosomal recessive | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MYPN CL E G H | 84665 | 23246 | OMIM:615248 | Cardiomyopathy, dilated, 1kk | | | | 217 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | MYPN CL E G H | 84665 | 23246 | OMIM:617336 | Nemaline myopathy 11, autosomal recessive | | | | 217 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | NEK1 CL E G H | 4750 | 7744 | OMIM:617892 | Amyotrophic lateral sclerosis, susceptibility to, 24 | | | | 101 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | NEXN CL E G H | 91624 | 29557 | OMIM:613122 | Cardiomyopathy, dilated, 1cc | | | | 167 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | NF1 CL E G H | 4763 | 7765 | OMIM:162210 | Neurofibromatosis, familial spinal | | | | 1952 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:619473 | OCULOPHARYNGODISTAL MYOPATHY 3; OPDM3 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | NOTCH3 CL E G H | 4854 | 7883 | OMIM:125310 | Cerebral arteriopathy, autosomal dominant, with subcortical infarctsand leukoencephalopathy | | | | 144 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | NPPA CL E G H | 4878 | 7939 | OMIM:612201 | Atrial fibrillation, familial, 6 | | | | 13 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | OPTN CL E G H | 10133 | 17142 | OMIM:613435 | Amyotrophic lateral sclerosis 12 | | | | 62 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PDGFRB CL E G H | 5159 | 8804 | OMIM:615007 | Basal ganglia calcification, idiopathic, 4 | | | | 28 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PHKA1 CL E G H | 5255 | 8925 | OMIM:300559 | Muscle glycogenosis, X-linked | | | | 54 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PKD2 CL E G H | 5311 | 9009 | OMIM:613095 | Polycystic kidney disease 2 | | | | 106 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PKHD1 CL E G H | 5314 | 9016 | OMIM:263200 | Polycystic kidney disease 4 with or without polycystic liver disease | | | | 563 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PLEKHG5 CL E G H | 57449 | 29105 | OMIM:615376 | Charcot-Marie-Tooth disease, recessive intermediate C | | | | 186 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PLN CL E G H | 5350 | 9080 | OMIM:613874 | Cardiomyopathy, familial hypertrophic, 18 | | | | 57 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | POLG CL E G H | 5428 | 9179 | OMIM:157640 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1 | | | | 464 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | POLG CL E G H | 5428 | 9179 | OMIM:258450 | Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessive | | | | 464 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | POLRMT CL E G H | 5442 | 9200 | OMIM:619743 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55; COXPD55 | | | | 1 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PRKN CL E G H | 5071 | 8607 | OMIM:600116 | Parkinson disease, juvenile, type 2 | | | | 138 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | 69 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PSAP CL E G H | 5660 | 9498 | OMIM:619491 | PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK24 | | | | 81 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PSEN1 CL E G H | 5663 | 9508 | OMIM:613694 | Cardiomyopathy, dilated, 1U | | | | 241 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PSEN1 CL E G H | 5663 | 9508 | OMIM:600274 | Frontotemporal dementia | | | | 241 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PSEN2 CL E G H | 5664 | 9509 | OMIM:606889 | Alzheimer disease 4 | | | | 59 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PSEN2 CL E G H | 5664 | 9509 | OMIM:613697 | Cardiomyopathy, dilated, 1V | | | | 59 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | PYGM CL E G H | 5837 | 9726 | OMIM:232600 | Glycogen storage disease V | | | | 166 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | RAB39B CL E G H | 116442 | 16499 | OMIM:311510 | Waisman syndrome | | | | 34 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | RAF1 CL E G H | 5894 | 9829 | OMIM:615916 | Cardiomyopathy, dilated, 1nn | | | | 212 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | RAX2 CL E G H | 84839 | 18286 | OMIM:620102 | | | | | 52 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | REEP1 CL E G H | 65055 | 25786 | OMIM:610250 | Spastic paraplegia 31, autosomal dominant | | | | 87 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | RELN CL E G H | 5649 | 9957 | OMIM:600512 | EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1 | | | | 334 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | RIPOR2 CL E G H | 9750 | 13872 | OMIM:607017 | Deafness, autosomal dominant 21 | | | | 1 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | RPA1 CL E G H | 6117 | 10289 | OMIM:619767 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 6; PFBMFT6 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | RPGR CL E G H | 6103 | 10295 | OMIM:300029 | Retinitis pigmentosa 3 | | | | 200 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | RRM2B CL E G H | 50484 | 17296 | OMIM:613077 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 | | | | 125 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SAMD9L CL E G H | 219285 | 1349 | OMIM:619806 | SPINOCEREBELLAR ATAXIA 49; SCA49 | | | | 4 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SCN1B CL E G H | 6324 | 10586 | OMIM:615377 | Atrial fibrillation, familial, 13 | | | | 126 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SCN2B CL E G H | 6327 | 10589 | OMIM:615378 | Atrial fibrillation, familial, 14 | | | | 21 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SCN3B CL E G H | 55800 | 20665 | OMIM:613120 | Brugada syndrome 7 | | | | 122 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SCN5A CL E G H | 6331 | 10593 | OMIM:614022 | Atrial fibrillation, familial, 10 | | | | 1134 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SDHA CL E G H | 6389 | 10680 | OMIM:619259 | NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA | | | | 304 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SEC23B CL E G H | 10483 | 10702 | OMIM:224100 | Anemia, dyserythropoietic congenital, type II | | | | 60 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SFTPA1 CL E G H | 653509 | 10798 | OMIM:619611 | INTERSTITIAL LUNG DISEASE 1; ILD1 | | | | 19 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:619525 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIw; CDG2W | | | | 110 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SMPD1 CL E G H | 6609 | 11120 | OMIM:607616 | Niemann-pick disease, type B | | | | 164 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SMPX CL E G H | 23676 | 11122 | OMIM:301075 | MYOPATHY, DISTAL, 7, ADULT-ONSET, X-LINKED; MPD7 | | | | 12 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SNCA CL E G H | 6622 | 11138 | OMIM:605543 | Parkinson disease 4 | . | | | 65 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SNORD118 CL E G H | 727676 | 32952 | OMIM:614561 | Leukoencephalopathy, brain calcifications, and cysts | | | | 6 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SOCS1 CL E G H | 8651 | 19383 | OMIM:619375 | AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY; AISIMD | | | | 6 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | SPTLC2 CL E G H | 9517 | 11278 | OMIM:613640 | Neuropathy, hereditary sensory and autonomic, type IC | | | | 149 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | STT3A CL E G H | 3703 | 6172 | OMIM:619714 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT; CDG1WAD | | | | 21 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TBK1 CL E G H | 29110 | 11584 | OMIM:617900 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8 | | | | 20 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TBP CL E G H | 6908 | 11588 | OMIM:607136 | Spinocerebellar ataxia 17 | | | | 7 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TBX18 CL E G H | 9096 | 11595 | OMIM:143400 | Congenital anomalies of kidney and urinary tract 2 | | | | 5 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TERT CL E G H | 7015 | 11730 | OMIM:613989 | Dyskeratosis congenita, autosomal dominant 2 | | | | 238 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TGFBI CL E G H | 7045 | 11771 | OMIM:121820 | Corneal dystrophy, epithelial basement membrane | | | | 58 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TGM6 CL E G H | 343641 | 16255 | OMIM:613908 | Spinocerebellar ataxia 35 | | | | 58 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | THSD1 CL E G H | 55901 | 17754 | OMIM:618734 | ANEURYSM, INTRACRANIAL BERRY, 12; ANIB12 | | | | 2 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | THSD4 CL E G H | 79875 | 25835 | OMIM:619825 | AORTIC ANEURYSM, FAMILIAL THORACIC 12; AAT12 | | | | 2 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TIA1 CL E G H | 7072 | 11802 | OMIM:619133 | AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26 | | | | 5 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TMEM240 CL E G H | 339453 | 25186 | OMIM:607454 | Spinocerebellar ataxia 21 | | | | 9 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TNNC1 CL E G H | 7134 | 11943 | OMIM:611879 | CARDIOMYOPATHY, DILATED, 1Z; CMD1Z | | | | 73 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TNNC1 CL E G H | 7134 | 11943 | OMIM:613243 | Cardiomyopathy, familial hypertrophic, 13 | | | | 73 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TNNI3 CL E G H | 7137 | 11947 | OMIM:613286 | Cardiomyopathy, dilated, 1ff | | | | 180 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TNNT2 CL E G H | 7139 | 11949 | OMIM:601494 | Cardiomyopathy, dilated, 1D | | | | 248 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TNNT2 CL E G H | 7139 | 11949 | OMIM:115195 | Cardiomyopathy, familial hypertrophic, 2 | | | | 248 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TOR1A CL E G H | 1861 | 3098 | OMIM:128100 | Dystonia 1, torsion, autosomal dominant | | | | 47 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TPM1 CL E G H | 7168 | 12010 | OMIM:611878 | Cardiomyopathy, dilated, 1Y | | | | 230 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TTLL5 CL E G H | 23093 | 19963 | OMIM:615860 | Cone-Rod dystrophy 19 | | | | 9 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | TTN CL E G H | 7273 | 12403 | OMIM:604145 | CARDIOMYOPATHY, DILATED, 1G; CMD1G | | | | 7128 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | UBA1 CL E G H | 7317 | 12469 | OMIM:301054 | VEXAS SYNDROME; VEXAS | | | | 35 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | UQCRC1 CL E G H | 7384 | 12585 | OMIM:619279 | PARKINSONISM WITH POLYNEUROPATHY; PKNPY | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | VAPB CL E G H | 9217 | 12649 | OMIM:608627 | Amyotrophic lateral sclerosis 8 | | | | 116 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | VAPB CL E G H | 9217 | 12649 | OMIM:182980 | Spinal muscular atrophy, proximal, adult, autosomal dominantspinal muscular atrophy, late-onset, finkel type, included | | | | 116 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | VCL CL E G H | 7414 | 12665 | OMIM:611407 | CARDIOMYOPATHY, DILATED, 1W; CMD1W | | | | 248 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | VCL CL E G H | 7414 | 12665 | OMIM:613255 | Cardiomyopathy, familial hypertrophic, 15 | | | | 248 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | VCP CL E G H | 7415 | 12666 | OMIM:613954 | Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia | | | | 63 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | VCP CL E G H | 7415 | 12666 | OMIM:167320 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 | | | | 63 | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | VPS16 CL E G H | 64601 | 14584 | OMIM:619291 | DYSTONIA 30; DYT30 | | | | | | | HP:0003596 | HP:0003596 | Middle age onset | 0 | ZNF408 CL E G H | 79797 | 20041 | OMIM:616469 | Retinitis pigmentosa 72 | | | | 14 | | |
Genes (168) :AARS1 ABCC9 ACTC1 ANXA11 APC APOE ATN1 ATP2B2 ATP6AP2 ATXN10 BAG3 BAP1 BMPR2 BRCA1 BVES CADM3 CAPN3 CASK CAV1 CCNF CDH2 CHCHD10 CHMP2B CHRNA1 CLCN2 CLEC3B CLN6 CNBP COL4A1 CRYAB CSF1R CYLD CYP7B1 DRD5 DSC2 DSG2 EIF2AK4 ELOVL4 EPCAM ERBB4 FBLN5 FBN1 FKTN FLNC FTL G6PD GANAB GATAD1 GBE1 GBF1 GJA5 GYG1 H6PD HAVCR2 HKDC1 HLA-DQB1 HNRNPA1 HTRA1 IKZF1 IMPG2 ITM2B JAK2 KCNA5 KCNC3 KCND3 KCNE2 KCNJ18 KCNJ2 KCNK3 KCNQ1 KIF1B KIF5A KNG1 LAMA4 LGI1 LITAF LMNA LMX1B LRIF1 LRP12 MAFA MAK MAP1B MAPT MARS1 MARS2 MATR3 MBD4 MICAL1 MLH1 MME MOCOS MPZ MSH2 MSH3 MYH6 MYORG MYPN NEK1 NEXN NF1 NOTCH2NLC NOTCH3 NPPA OPTN PDGFRB PHKA1 PKD2 PKHD1 PLEKHG5 PLN POLG POLRMT PRKN PRNP PSAP PSEN1 PSEN2 PYGM RAB39B RAF1 RAX2 REEP1 RELN RIPOR2 RPA1 RPGR RRM2B SAMD9L SCN1B SCN2B SCN3B SCN5A SDHA SEC23B SFTPA1 SLC37A4 SMPD1 SMPX SNCA SNORD118 SOCS1 SPTLC2 STT3A TBK1 TBP TBX18 TERT TGFBI TGM6 THSD1 THSD4 TIA1 TMEM240 TNNC1 TNNI3 TNNT2 TOR1A TPM1 TTLL5 TTN UBA1 UQCRC1 VAPB VCL VCP VPS16 ZNF408
Diseases (175) :OMIM:613287 OMIM:614050 OMIM:608569 OMIM:613424 OMIM:612098 OMIM:617839 OMIM:619733 OMIM:135290 OMIM:606889 OMIM:125370 OMIM:619804 OMIM:300911 OMIM:603516 OMIM:613881 OMIM:614327 OMIM:178600 OMIM:604370 OMIM:616812 OMIM:619519 OMIM:618129 OMIM:300908 OMIM:615343 OMIM:619141 OMIM:618920 OMIM:615911 OMIM:615048 OMIM:600795 OMIM:601462 OMIM:615651 OMIM:619977 OMIM:204300 OMIM:602668 OMIM:618564 OMIM:615184 OMIM:221820 OMIM:619132 OMIM:270800 OMIM:606798 OMIM:610476 OMIM:610193 OMIM:234810 OMIM:133190 OMIM:613244 OMIM:615515 OMIM:608895 OMIM:129600 OMIM:611615 OMIM:617047 OMIM:606159 OMIM:600666 OMIM:614672 OMIM:263570 OMIM:606483 OMIM:614049 OMIM:616199 OMIM:604931 OMIM:618398 OMIM:619614 OMIM:123400 OMIM:615424 OMIM:600142 OMIM:616779 OMIM:616873 OMIM:616152 OMIM:616079 OMIM:263300 OMIM:612240 OMIM:605259 OMIM:616399 OMIM:611493 OMIM:613239 OMIM:613980 OMIM:615344 OMIM:607554 OMIM:118210 OMIM:617921 OMIM:619363 OMIM:615235 OMIM:600512 OMIM:601098 OMIM:115200 OMIM:256020 OMIM:619477 OMIM:164310 OMIM:147630 OMIM:614181 OMIM:619808 OMIM:600274 OMIM:616280 OMIM:611390 OMIM:606070 OMIM:619975 OMIM:158320 OMIM:617018 OMIM:603592 OMIM:607736 OMIM:617100 OMIM:613252 OMIM:618317 OMIM:615248 OMIM:617336 OMIM:617892 OMIM:613122 OMIM:162210 OMIM:619473 OMIM:125310 OMIM:612201 OMIM:613435 OMIM:615007 OMIM:300559 OMIM:613095 OMIM:263200 OMIM:615376 OMIM:613874 OMIM:157640 OMIM:258450 OMIM:619743 OMIM:600116 OMIM:619491 OMIM:613694 OMIM:613697 OMIM:232600 OMIM:311510 OMIM:615916 OMIM:620102 OMIM:610250 OMIM:607017 OMIM:619767 OMIM:300029 OMIM:613077 OMIM:619806 OMIM:615377 OMIM:615378 OMIM:613120 OMIM:614022 OMIM:619259 OMIM:224100 OMIM:619611 OMIM:619525 OMIM:607616 OMIM:301075 OMIM:605543 OMIM:614561 OMIM:619375 OMIM:613640 OMIM:619714 OMIM:617900 OMIM:607136 OMIM:143400 OMIM:613989 OMIM:121820 OMIM:613908 OMIM:618734 OMIM:619825 OMIM:619133 OMIM:607454 OMIM:611879 OMIM:613243 OMIM:613286 OMIM:601494 OMIM:115195 OMIM:128100 OMIM:611878 OMIM:615860 OMIM:604145 OMIM:301054 OMIM:619279 OMIM:608627 OMIM:182980 OMIM:611407 OMIM:613255 OMIM:613954 OMIM:167320 OMIM:619291 OMIM:616469 |
Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.
|
|
|